Author:
Chapple Christopher,Van Kerrebroeck Philip,Tubaro Andrea,Haag-Molkenteller Cornelia,Forst Hans-Theo,Massow Ute,Wang Joseph,Brodsky Marina
Reference20 articles.
1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003
2. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int,2001
3. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006
4. Emerging pharmacologic approaches for the treatment of lower urinary tract disorders;Moreland;J Pharmacol Exp Ther,2004
5. Nitti V, Wiatrak M, Kreitman L, Lipsitz D. Fesoterodine is an effective antimuscarinic for patients with overactive bladder (OAB): results of a phase 2 trial. Paper presented at International Continence Society, Montreal, Canada, August 31–September 2, 2005.
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献